Market revenue in 2022 | USD 38.9 million |
Market revenue in 2030 | USD 108.2 million |
Growth rate | 13.7% (CAGR from 2022 to 2030) |
Largest segment | Gene panel, ldt & others |
Fastest growing segment | Gene Panel, LDT & Others |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gene Panel, LDT & Others |
Key market players worldwide | Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.
Gene panel, ldt & others was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the Italy multi cancer early detection market based on gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
In August 2022, the Lung Ambition Alliance—launched by the International Association for the Study of Lung Cancer, the Worldwide Lung Cancer Coalition, AstraZeneca, and Guardant Health— established the Lung Cancer Policy Network as a multi stake holder global project.
AstraZeneca, Guardant Health, Johnson & Johnson, and Medtronic provided funding for the initiative, which aimed at enhancing cancer screening in Italy. Moreover, the country’s market is supported by increasing government initiatives and innovations in technology & approach to cancer screening & diagnosis, providing proper treatment options to patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy multi cancer early detection market , including forecasts for subscribers. This country databook contains high-level insights into Italy multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account